• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effect of intravitreal ranibizumab on fibrovascular membranes in patients with proliferative diabetic retinopathy.玻璃体内注射雷珠单抗对增殖性糖尿病视网膜病变患者纤维血管膜的影响。
Int J Ophthalmol. 2022 Oct 18;15(10):1577-1585. doi: 10.18240/ijo.2022.10.03. eCollection 2022.
2
Reduced Expression of Erythropoietin After Intravitreal Ranibizumab in Proliferative Diabetic Retinopathy Patients-Retrospective Interventional Study.雷珠单抗玻璃体腔内注射治疗增殖性糖尿病视网膜病变患者后促红细胞生成素表达降低——回顾性干预研究
Front Med (Lausanne). 2021 Sep 21;8:710079. doi: 10.3389/fmed.2021.710079. eCollection 2021.
3
Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy.玻璃体内注射雷珠单抗预处理对年轻增殖性糖尿病视网膜病变患者玻璃体切除术的影响。
Ann Palliat Med. 2020 Jan;9(1):82-89. doi: 10.21037/apm.2020.01.10.
4
Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy.肌腱蛋白-C促进增殖性糖尿病视网膜病变患者眼内纤维血管膜的血管生成。
Mol Vis. 2016 Apr 30;22:436-45. eCollection 2016.
5
The impact of ranibizumab on the level of intercellular adhesion molecule type 1 in the vitreous of eyes with proliferative diabetic retinopathy.雷珠单抗对增殖性糖尿病视网膜病变患者眼玻璃体内细胞间黏附分子1水平的影响。
Acta Ophthalmol. 2016 Jun;94(4):358-64. doi: 10.1111/aos.12806. Epub 2015 Aug 18.
6
Characterization of cells from patient-derived fibrovascular membranes in proliferative diabetic retinopathy.增殖性糖尿病视网膜病变患者来源的纤维血管膜细胞的特征分析
Mol Vis. 2015 Jun 12;21:673-87. eCollection 2015.
7
The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage.玻璃体切割术治疗增生性糖尿病视网膜病变伴玻璃体积血前玻璃体内注射雷珠单抗的疗效和安全性。
BMC Ophthalmol. 2022 Feb 10;22(1):63. doi: 10.1186/s12886-022-02303-3.
8
Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy.玻璃体内注射雷珠单抗治疗增生性糖尿病视网膜病变后出现鬼影细胞性青光眼。
BMC Ophthalmol. 2020 Apr 15;20(1):149. doi: 10.1186/s12886-020-01422-z.
9
Localization of Acrolein-Lysine Adduct in Fibrovascular Tissues of Proliferative Diabetic Retinopathy.丙烯醛-赖氨酸加合物在增殖性糖尿病视网膜病变纤维血管组织中的定位
Curr Eye Res. 2017 Jan;42(1):111-117. doi: 10.3109/02713683.2016.1150491. Epub 2016 Jun 1.
10
Increased expression of periostin in vitreous and fibrovascular membranes obtained from patients with proliferative diabetic retinopathy.骨膜蛋白在增生性糖尿病视网膜病变患者的玻璃体和纤维血管膜中的表达增加。
Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5670-8. doi: 10.1167/iovs.10-6625.

本文引用的文献

1
Proliferative diabetic retinopathy transcriptomes reveal angiogenesis, anti-angiogenic therapy escape mechanisms, fibrosis and lymphatic involvement.增生型糖尿病性视网膜病变转录组揭示了血管生成、抗血管生成治疗逃逸机制、纤维化和淋巴血管受累。
Sci Rep. 2021 Sep 22;11(1):18810. doi: 10.1038/s41598-021-97970-5.
2
Gliotic opaque posterior hyaloid membrane separation: report of two cases.玻璃体细胞性后脱离的后极部混浊后脱离膜:两例报告。
BMC Ophthalmol. 2021 Aug 23;21(1):308. doi: 10.1186/s12886-021-02072-5.
3
CD146/Soluble CD146 Pathway Is a Novel Biomarker of Angiogenesis and Inflammation in Proliferative Diabetic Retinopathy.CD146/可溶性 CD146 通路是增生型糖尿病视网膜病变中血管生成和炎症的新的生物标志物。
Invest Ophthalmol Vis Sci. 2021 Jul 1;62(9):32. doi: 10.1167/iovs.62.9.32.
4
Role of bevacizumab intraocular injection in the management of neovascular glaucoma.贝伐单抗眼内注射在新生血管性青光眼治疗中的作用
Int J Ophthalmol. 2021 Jun 18;14(6):855-859. doi: 10.18240/ijo.2021.06.10. eCollection 2021.
5
Vitreous from idiopathic epiretinal membrane patients induces glial-to-mesenchymal transition in Müller cells.特发性视网膜前膜患者的玻璃体诱导 Müller 细胞发生胶质到间充质转化。
Biochim Biophys Acta Mol Basis Dis. 2021 Oct 1;1867(10):166181. doi: 10.1016/j.bbadis.2021.166181. Epub 2021 Jun 1.
6
Cell-Matrix Interactions in the Eye: From Cornea to Choroid.眼睛中的细胞-基质相互作用:从角膜到脉络膜。
Cells. 2021 Mar 20;10(3):687. doi: 10.3390/cells10030687.
7
VEGFR1 signaling in retinal angiogenesis and microinflammation.VEGFR1 信号在视网膜血管生成和微炎症中的作用。
Prog Retin Eye Res. 2021 Sep;84:100954. doi: 10.1016/j.preteyeres.2021.100954. Epub 2021 Feb 25.
8
Perioperative anti-vascular endothelial growth factor agents treatment in patients undergoing vitrectomy for complicated proliferative diabetic retinopathy: a network meta-analysis.接受玻璃体切除术治疗复杂性增生型糖尿病视网膜病变患者的围手术期抗血管内皮生长因子药物治疗:一项网状荟萃分析。
Sci Rep. 2020 Nov 3;10(1):18880. doi: 10.1038/s41598-020-75896-8.
9
Increased vitreal levels of interleukin-10 in diabetic retinopathy: a Meta-analysis.糖尿病性视网膜病变中玻璃体内白细胞介素-10水平升高:一项Meta分析。
Int J Ophthalmol. 2020 Sep 18;13(9):1477-1483. doi: 10.18240/ijo.2020.09.21. eCollection 2020.
10
Vitreous levels of vascular endothelial growth factor, stromal cell-derived factor-1α, and angiopoietin-like protein 2 in patients with active proliferative diabetic retinopathy.患者患有活动期增生性糖尿病视网膜病变时玻璃体中血管内皮生长因子、基质细胞衍生因子-1α 和血管生成素样蛋白 2 的水平。
Graefes Arch Clin Exp Ophthalmol. 2021 Jan;259(1):53-60. doi: 10.1007/s00417-020-04889-0. Epub 2020 Aug 19.

玻璃体内注射雷珠单抗对增殖性糖尿病视网膜病变患者纤维血管膜的影响。

Effect of intravitreal ranibizumab on fibrovascular membranes in patients with proliferative diabetic retinopathy.

作者信息

Liang Ze-Yu, Wang Yi-Peng, Li Jing, Yang Wen-Chao, Tu Yong-Fang, Zhang Yue, Chen Song

机构信息

Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Lab of Ophthalmology and Visual Science, Nankai University Affiliated Eye Hospital, Tianjin 300020, China.

Anyang Eye Hospital, Anyang 455000, Henan Province, China.

出版信息

Int J Ophthalmol. 2022 Oct 18;15(10):1577-1585. doi: 10.18240/ijo.2022.10.03. eCollection 2022.

DOI:10.18240/ijo.2022.10.03
PMID:36262844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9522570/
Abstract

AIM

To assess the effects of intravitreal ranibizumab (IVR) on angiogenesis and glial activity of the fibrovascular membrane (FVM) in patients with proliferative diabetic retinopathy (PDR).

METHODS

Forty-two eyes from 42 patients with PDR requiring vitrectomy were included and divided into two groups: control group (=16) did not receive IVR, while IVR group (=26) underwent IVR 5d before vitrectomy. FVM specimens were collected by the same surgeon during the interventions. Histopathological morphology was examined by hematoxylin-eosin (H-E) staining and cell densities in the FVM was assessed. Microvessels were outlined by immunohistochemical staining of CD31 and microvessel density (MVD) assessed as an index of FVM angiogenesis. Dual-color immunofluorescence staining, and confocal microscopy was used to detect co-localization and relative expression levels of glial fibrillary acidic protein (GFAP) and α-smooth muscle actin (α-SMA) as markers of glial-mesenchymal transition (GMT). The GMT index (GI; ratio of relative GFAP/α-SMA expression) was used to semi-quantify the degree of GMT or glial activity of FVMs.

RESULTS

H-E staining showed similar vascularization in both groups, with microvessels and scattered stromal cells in the matrix. Infiltrated cell densities did not differ significantly between the two groups (>0.05). The MVD of the IVR group (130.62±15.46/mm) was significantly lower than that of the controls (142.25±19.16/mm, <0.05). In both groups, all sections were strongly immunostained for GFAP and α-SMA. The Pearson's correlation coefficients (PCC) of intensity of automated pixel count of two markers indicated GFAP and α-SMA co-stained well and GMT participated in the remolding of FVMs in PDR. The mean relative GFAP expression in the IVR group was significantly lower, whereas that of α-SMA was significantly higher than in controls (<0.05). GI in the IVR group (1.10±0.10) was significantly lower than in the controls (1.21±0.12, <0.05).

CONCLUSION

IVR can reduce angiogenesis, glial activity of FVM and promote glial-fibrotic transformation by reducing MVD and promoting GMT but does not decrease the cell density in patients with PDR.

摘要

目的

评估玻璃体内注射雷珠单抗(IVR)对增殖性糖尿病视网膜病变(PDR)患者纤维血管膜(FVM)血管生成和神经胶质细胞活性的影响。

方法

纳入42例需要进行玻璃体切除术的PDR患者的42只眼,分为两组:对照组(n = 16)未接受IVR,而IVR组(n = 26)在玻璃体切除术前5天接受IVR。在干预过程中由同一位外科医生收集FVM标本。通过苏木精 - 伊红(H-E)染色检查组织病理学形态,并评估FVM中的细胞密度。通过CD31免疫组织化学染色勾勒微血管,并评估微血管密度(MVD)作为FVM血管生成的指标。采用双色免疫荧光染色和共聚焦显微镜检测神经胶质纤维酸性蛋白(GFAP)和α-平滑肌肌动蛋白(α-SMA)的共定位及相对表达水平,作为神经胶质 - 间充质转化(GMT)的标志物。GMT指数(GI;相对GFAP/α-SMA表达的比值)用于半定量FVM的GMT程度或神经胶质细胞活性。

结果

H-E染色显示两组的血管化情况相似,基质中有微血管和散在的基质细胞。两组间浸润细胞密度无显著差异(P>0.05)。IVR组的MVD(130.62±15.46/mm)显著低于对照组(142.25±19.16/mm,P<0.05)。在两组中,所有切片对GFAP和α-SMA均有强免疫染色。两种标志物自动像素计数强度的Pearson相关系数(PCC)表明GFAP和α-SMA共染色良好,且GMT参与了PDR中FVM的重塑。IVR组中GFAP的平均相对表达显著较低,而α-SMA的平均相对表达显著高于对照组(P<0.05)。IVR组的GI(1.10±0.10)显著低于对照组(1.21±0.12,P<0.05)。

结论

IVR可通过降低MVD和促进GMT来减少PDR患者FVM的血管生成、神经胶质细胞活性,并促进神经胶质 - 纤维化转化,但不降低细胞密度。